300726-25-4

Basic information

• Product Name: 2-((5-amino-1,3,4-thiadiazol-2-yl)thio)-1-phenylethanone
• Synonyms: 2-((5-amino-1,3,4-thiadiazol-2-yl)thio)-1-phenylethanone
• CAS NO: 300726-25-4
• Molecular Weight: 251.333
• Mol File: 300726-25-4.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 2-((5-amino-1,3,4-thiadiazol-2-yl)thio)-1-phenylethanone(CAS DataBase Reference)
• NIST Chemistry Reference: 2-((5-amino-1,3,4-thiadiazol-2-yl)thio)-1-phenylethanone(300726-25-4)
• EPA Substance Registry System: 2-((5-amino-1,3,4-thiadiazol-2-yl)thio)-1-phenylethanone(300726-25-4)

Safety Data

• Hazardous Substances Data: 300726-25-4(Hazardous Substances Data)

Usage

Structure

Thiadiazole ring A 5-membered heterocyclic ring containing sulfur and nitrogen atoms.

Amino group attachment

5-position An amino group (-NH2) is attached to the thiadiazole ring at the 5th position, contributing to its biological activity.

Thiol group

-SH group A sulfur-hydrogen group (-SH) is present in the compound, which is known for its significant biological activity and potential antioxidant properties.

Phenylethanone group

C6H5-CH2-COA phenyl group (C6H5) connected to an ethanone group (CH3-CO-), suggesting potential anti-inflammatory properties.

Pharmaceutical and medical applications

Potential uses Due to the presence of biologically active groups, this compound may have applications in drug development and treatment of various diseases or conditions.

Central nervous system and inflammation treatment

Target areas The compound may be particularly useful in treating diseases or conditions affecting the central nervous system or inflammation due to its amino and thiol groups.

Antioxidant and anti-inflammatory properties

Phenylethanone group The presence of the phenylethanone group suggests potential antioxidant and anti-inflammatory properties, which may contribute to its therapeutic effects.

Further research and testing

Necessary for understanding potential uses and effects More studies are needed to fully comprehend the potential applications and effects of 2-((5-amino-1,3,4-thiadiazol-2-yl)thio)-1-phenylethanone in pharmaceutical and medical fields.

Upstream product

• 98-86-2 acetophenone 
• 70-11-1 α-bromoacetophenone 
• 2349-67-9 2-Amino-5-mercapto-1,3,4-thiadiazole 

Downstream Products

• 1220687-95-5 7-hydroxy-2-(phenacylsulfanyl)-6-undecyl[1,3,4]thiadiazolo[3,2-a]benzimidazole-5,8-dione 
• 1378026-81-3 1-cyclopropyl-6-fluoro-1,4-dihydro-7-[4-{5-(2-oxo-2-phenylethylthio)-1,3,4-thiadiazol-2-yl}piperazin-1-yl]-4-oxoquinoline-3-carboxylic acid 
• 1378026-80-2 C₁₀H₇ClN₂OS₂ 
• 1378026-82-4 1-ethyl-6-fluoro-1,4-dihydro-7-[4-{5-(2-oxo-2-phenylethylthio)-1,3,4-thiadiazol-2-yl}piperazin-1-yl]-4-oxoquinoline-3-carboxylic acid 

Relevant articles and documents

Design, Synthesis, SAR and Molecular Modeling Studies of Novel Imidazo[2,1-b][1,3,4]Thiadiazole Derivatives as Highly Potent Antimicrobial Agents

In this study, a novel series of phenyl substituted imidazo[2,1-b][1,3,4]thiadiazole derivatives were synthesized, characterized and explored for antibacterial activity against Gram-negative Escherichia coli, Gram-positive Staphylococcus aureus and Bacillus subtilis and antifungal activity against Candida albicans. Most of the synthesized compounds exhibited remarkable antimicrobial activities, some of which being ten times more potent than positive controls. The most promising compound showed excellent activity with MIC value of 0.03 μg/ml against both S. aureus and B. subtilis (MIC values of positive compound Chloramphenicol are 0.4 μg/ml and 0.85 μg/ml, respectively). Furthermore, structure-activity relationship was also investigated with the help of computational tools. Some physicochemical and ADME properties of the compounds were calculated too. The combination of electronic structure calculations performed at PM6 level and molecular docking simulations using Glide extra-precision mode showed that the hydrophobic nature of keto aryl ring with no electron withdrawing substituents at para position enhances activity while electron-donating substituents at the second aryl ring is detrimental to activity.

Synthesis of 2-alkyl/arylalkyl/phenacylsul-fanyl-1 -thia-3,3, 10-triaza-pentaleno[ 1,2-b]naphthalene-4,9-dione

2,3-Dichloronaphthoquinone is condensed with 5-(alkyl/arylalkyl/ phenacylthio)-1,3,4-thiadiazol-2-amine in acetic acid to furnish a novel and hitherto unknown 2-alkyl/aralkyl/phenacylsulfanyl-1-thia-3,3a,10-triaza- pentaleno[1,2-b]naphthalene-4,9-dione. The structure of the synthesized compound has been confirmed by converting it into the corresponding reductive acetate. The structures of newly prepared compounds have been confirmed by analytical and spectral data.